Oral Presentation 30th Lorne Cancer Conference 2018

CESTEM-1 clinical trials using dynamin inhibitors to reverse resistance to monoclonal antibody therapy (#16)

Shannon R Joseph 1 , Katharine Cuff 2 , Godwins Echejoh 1 , Hui Yi Chew 1 , Blerida Banushi 1 , Brigid King 1 , Sally Yukiko 1 , Priscilla De Olivia 1 , Annabelle Genko 1 , Alexander Grainger 1 , Satomi Okano 1 , Ian H Frazer 1 , James Wells 1 , Jermaine Coward 3 4 , Matthew Foote 5 , Jennifer Martin 6 , Ben Panizza 2 3 , Euan Walpole 2 4 , Fiona Simpson 1 3
  1. University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, QLD, Australia
  2. Faculty of Medicine , University of QLD, Woolloongabba, QLD, Australia
  3. Queensland Head and Neck Cancer Centre and The Department of Otolaryngology - Head and Neck Surgery, Princess Alexandra Hospital, Woolloongabba, QLD, Australia
  4. Cancer Services, Department of Oncology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia
  5. Department of Radiation Oncology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia
  6. School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia
Publish consent withheld